Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $0.59.

  • Healthequity's EPS (Weighted Average and Diluted) rose 88333.33% to $0.59 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.18, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $1.09 for FY2025, which is 7010.23% up from last year.
  • Healthequity's EPS (Weighted Average and Diluted) amounted to $0.59 in Q4 2025, which was up 88333.33% from $0.68 recorded in Q3 2025.
  • Over the past 5 years, Healthequity's EPS (Weighted Average and Diluted) peaked at $0.68 during Q3 2025, and registered a low of -$0.39 during Q1 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.14, with a median of $0.06 in 2021.
  • As far as peak fluctuations go, Healthequity's EPS (Weighted Average and Diluted) crashed by 215494.97% in 2021, and later soared by 1222086.12% in 2024.
  • Healthequity's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.06 in 2021, then surged by 67.82% to -$0.02 in 2022, then soared by 976.13% to $0.17 in 2023, then plummeted by 64.71% to $0.06 in 2024, then surged by 883.33% to $0.59 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.59 in Q4 2025, compared to $0.68 in Q3 2025 and $0.61 in Q2 2025.